Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors
作者:Ghaneya S. Hassan、Hanan H. Georgey、Esraa Z. Mohammed、Farghaly A. Omar
DOI:10.1016/j.ejmech.2019.111747
日期:2019.12
The present study reports on evaluation of anti-HCV activity and QSAR of certain arylidenethiazolidinone derivatives as potential inhibitors of HCV-NS5B polymerase. The pursued compounds involving, 5-aryliden-3-arylacetamidothiazolidin-2,4-diones 4-6(a-f), 5-arylidine-2-(N-arylacetamido)-iminothiazolidin-4-one (10) and their rigid counterparts 5-arylidinethiazolotriazines 13-15(a-f), were synthesized
本研究报告了评估某些亚芳基噻唑烷酮衍生物作为 HCV-NS5B 聚合酶的潜在抑制剂的抗 HCV 活性和 QSAR。所追求的化合物包括 5-aryliden-3-arylacetamidothiazolidin-2,4-diones 4-6(af)、5-arylidine-2-(N-arylacetamido)-iminothiazolidin-4-one (10) 及其刚性对应物 5合成了 -arylidinethiazolotriazines 13-15(af),并通过光谱和元素分析确认了它们的结构。NS5B 聚合酶抑制试验的结果显示,化合物 4e 是最有效的抑制剂(IC50 = 0.035 μM),是参考药物 VCH-759(IC50 = 0.14 μM)的四倍。同时,化合物 4b、4c、5a 和 5c 以及 13b、14e 和 15c 显示出比 VCH-759 高 2 倍的活性(IC50